I

ImmunoMet Therapeutics, Inc.

7 employees

ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Fibrosis and Oncology
Therapeutics
Pharmaceutical
Biopharma

Date founded

2015

Funding rounds raised

Total raised

$7M

from 3 investors over 3 rounds

I

ImmunoMet Therapeutics, Inc. raised $7M on February 8, 2021

Investors: GNTech Venture Capital | 지앤텍벤처투자

I

ImmunoMet Therapeutics, Inc. raised $5M on March 7, 2017

Investors: INTERVEST-Mortgage Investment Co. and GNTech Venture Capital | 지앤텍벤처투자

FAQ